Gary Ingenito, Chief Medical Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 11,836 shares at $16.85 ($199K) on 2022-12-06, disclosed to the SEC on 2022-12-08.
Seasonal sale ($199k) by Chief Medical Officer — this insider has traded CPRX in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.85 | 5,918 | $100K | 50.0% |
| 2 | $16.85 | 5,918 | $100K | 50.0% |
| Total | $16.85 avg | 11,836 | $199K | 100% |
| Filing → |
| CPRX | SELL | 2024-11-29 | $545K | — | Filing → |
| CPRX | SELL | 2024-11-22 | $806K | — | Filing → |
| CPRX | SELL | 2024-08-13 | $1.8M | — | Filing → |